The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
Clinical trial NCT07314047 · RECRUITING
Trial details
- NCT number
- NCT07314047
- Sponsor
- MicroPort NeuroTech Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2025-05-28
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.